Uncategorized
Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment
Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure. read more
AT&T and Verizon Contain Cyberattack Linked to China’s Salt Typhoon Group
AT&T and Verizon announced their networks are secure after China-linked cyberespionage attack. Both stocks are down. U.S. officials concerned about China’s hacking program. read more
Cannabis In 2025: Inside America’s Social, Economic, Wellness Transformation
As 2025 dawns, a cultural revolution is blooming in the US, with cannabis emerging as a transformative force across all sectors of society. read more
Why Is Development-Stage Biotech Company Polyrizon Stock Surging Today?
Polyrizon shares rise after disclosing the publication of a national phase patent application for nasal protection and drug delivery technologies. read more